Literature DB >> 10213508

Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3.

Y Daigo1, T Nishiwaki, T Kawasoe, M Tamari, E Tsuchiya, Y Nakamura.   

Abstract

The short arm of chromosome 3 is thought to contain multiple tumor suppressor genes, because one copy of this chromosomal arm frequently is missing in carcinomas that have arisen in a variety of tissues. We have isolated a novel gene encoding a 1755-amino acid polypeptide, through large-scale sequencing of genomic DNA at 3p21.3. Mutational analysis of this gene by reverse transcription-PCR revealed the lack of functional transcripts and an increase of nonfunctional RNA transcripts in a significant proportion (33%) of cancer cell lines and primary cancers (4 of 14 esophageal cancer cell lines, 2 of 2 renal cancer cell lines, 11 of 30 primary non-small cell lung cancers, and 3 of 10 primary squamous cell carcinomas of the esophagus). However, no alterations of the gene itself were detected in any of the cancers examined. Introduction of the cDNA significantly suppressed the growth of four different cancer cell lines, two of which produced no normal transcript on their own. No such effect occurred when antisense cDNA, cDNA corresponding to an aberrant transcript, or the vector DNA alone were transfected. These data suggest that aberrant transcription of this gene, designated DLC1 (deleted in lung cancer 1), may be involved in carcinogenesis of the lung, esophagus, and kidney.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213508

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients.

Authors:  S Dasgupta; S B Chakraborty; A Roy; S Roychowdhury; C K Panda
Journal:  Mol Pathol       Date:  2003-10

2.  Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.

Authors:  Joseph Kwong; Ji-Young Lee; Kwong-Kwok Wong; Xiaofeng Zhou; David T W Wong; Kwok-Wai Lo; William R Welch; Ross S Berkowitz; Samuel C Mok
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

3.  DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.

Authors:  Lian Zhang; Qian Zhang; LiLi Li; Zhaohui Wang; Jianming Ying; Yu Fan; Qun He; Tianjing Lv; Wenke Han; Jun Li; Yang Yang; Ben Xu; Lu Wang; Qianling Liu; Yinghao Sun; Yinglu Guo; Qian Tao; Jie Jin
Journal:  J Mol Med (Berl)       Date:  2015-02-05       Impact factor: 4.599

4.  Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.

Authors:  G Marra; S D'Atri; C Corti; L Bonmassar; M S Cattaruzza; P Schweizer; K Heinimann; Z Bartosova; M Nyström-Lahti; J Jiricny
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  GADD45A expression is correlated with patient prognosis in esophageal cancer.

Authors:  Hideyuki Ishiguro; Masahiro Kimura; Hiroki Takahashi; Tatsuya Tanaka; Koji Mizoguchi; Hiromitsu Takeyama
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

6.  Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.

Authors:  Maria Kost-Alimova; Hajnalka Kiss; Ludmila Fedorova; Ying Yang; Jan P Dumanski; George Klein; Stefan Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

7.  Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.

Authors:  Yue Guo; Limin Shu; Chengyue Zhang; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2015-01-29       Impact factor: 5.858

8.  Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.

Authors:  Tatsuya Tanaka; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Takeyasu Katada; Midori Shiozaki; Yasuhiro Naganawa; Yoshitaka Fujii; Hiromitsu Takeyama
Journal:  J Exp Clin Cancer Res       Date:  2010-06-28

9.  Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients.

Authors:  Hidefumi Sasaki; Yu Hikosaka; Osamu Kawano; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

10.  Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.

Authors:  Chi-An Chen; Ying-Cheng Chiang; Ming-Cheng Chang; Yu-Hao Hu; San-Lin You; Yeu-Yao Kevin Cheng; Cheng-Yang Chou; Wen-Fang Cheng
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.